“Administration of physostigmine , unlike that of neostigmine, was associated with statistically significant increases in plasma concentrations of cortisol, prolactin, ACTH , beta-endorphin/beta-lipotropin-like immunoreactivity, and epinephrine, presumably via central mechanisms.”